Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

18 févr. 2026 10h47 HE | Source: Research and Markets

TIGIT Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 18+ Companies and 20+ Drugs

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "TIGIT Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report presents in-depth insights into...
10 févr. 2026 04h06 HE | Source: Research and Markets

EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "EZH2 Targeted Therapy Market Opportunity, Approved Drug Price, Sales and Clinical Trials Insight 2026" report has been added to ...
10 déc. 2025 09h15 HE | Source: Research and Markets

China Leads Therapeutic Access with 74 Approved Immuno-Oncology Agents

Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Immuno-oncology (2025)" has been added to ResearchAndMarkets.com's offering. The latest report delves into the dynamic...
05 nov. 2025 04h08 HE | Source: Research and Markets

Precision Oncology Research Report 2025: Market to Hit $158.9 Billion by 2029 as Genomics Diagnostics, Liquid Biopsies, Single-Cell Sequencing and Patient-Specific Cancer Vaccines Accelerate Adoption

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Precision Oncology Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The precision oncology market size has grown rapidly...
22 sept. 2025 04h32 HE | Source: Research and Markets

Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030: Advances in Next-Gen Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth

Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The revenue...
08 sept. 2025 10h39 HE | Source: Research and Markets

Trends & Strategies in the $54 Billion PD-1 & PD-L1 Inhibitors Market 2025: Industry Revenues Will More Than Double by 2030

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "PD-1 & PD-L1 Inhibitors Market Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The PD-1 & PD-L1 Inhibitors...
26 août 2025 10h41 HE | Source: Research and Markets

Oncolytic Virotherapies Analytical Tool: Navigating the Future of Cancer Research

Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Oncolytic Virotherapy Market with Confidence" directory has been added to ResearchAndMarkets.com's offering. The...
06 août 2025 04h24 HE | Source: Research and Markets

Tetraspecific Antibodies Market Research 2025-2029 | Molecular Partners, Innate Pharma, and ModeX Therapeutics Lead Innovations for Oncology and Autoimmune

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added...
13 juin 2025 11h13 HE | Source: Research and Markets

Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Report: Multispecific Antibodies Market to Surpass USD 50 Billion by 2030

Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030" report has been added to ...
08 mai 2025 05h16 HE | Source: Research and Markets

Histone Deacetylase (HDAC) 6 Pipeline Landscape 2025: In-Depth Insights Into Over 20 Companies and 26 Drugs Within the HDAC 6 Inhibitors Pipeline

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Histone Deacetylase 6 - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers a detailed analysis...

Page suivante